| Market Cap | ₹1,647Cr | 
| ROE | 15.07% | 
| P/E Ratio(TTM) | 50.67 | 
| EPS(TTM) | 6.24 | 
| P/B Ratio | 7.79 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 67.33 | 
| Book Value | 40.56 | 
| Debt to Equity | 0.42 | 
| Face Value | 2 | 
| Parent Organisation | Suraksha Diagnostic | 
| NSE Symbol | SURAKSHA | 
| FUND NAME | AUM(%) | 
|---|---|
| Nippon India Pharma Fund Direct Growth | 1.43% | 
| JM Value Fund Direct Plan Growth | 0.72% | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Dr Lal PathLabs | NA (0.00%)  | 50.47  | ||
| Vijaya Diagnostic Centre | NA (0.00%)  | 69.36  | ||
| Metropolis Healthcare | NA (0.00%)  | 68.04  | ||
| Thyrocare Technologies | NA (0.00%)  | 57.90  |